Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAXIVA: Axitinib in RCC with Venous Tumour Thrombus
NCT03494816Phase 2Completed
- Sponsor
- Scottish Clinical Trials Research Unit
- Start
- Dec 2017
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of axitinib in renal cell carcinoma (RCC), sponsored by Scottish Clinical Trials Research Unit. Started Dec 2017; status: completed.
02
Drugs
axitinib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT03494816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03494816.